Tatva Chintan Pharma Chem Profit & Loss Annual

Trade
BSE: 543321 | NSE: TATVA | ISIN: INE0GK401011 | Sector: Chemical Manufacturing
822.00 -1.00 (-0.12%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 393.50423.61433.65300.36
Total Revenue 393.50423.61433.65300.36
Costof Revenue Total 174.18258.20230.30168.28
Gross Profit 219.32165.41203.35132.08
Selling/ General/ Admin Expenses Total 54.7697.3994.8365.57
Depreciation/ Amortization 25.619.568.186.73
Other Operating Expenses Total 96.370.130.160.00
Total Operating Expense 350.91365.28333.46240.59
Operating Income 42.5958.34100.1959.77
Interest Inc( Exp) Net- Non- Op Total -65.32-114.0144.541.03
Gain( Loss)on Saleof Assets 0.00-35.88-0.51-0.34
Other Net 7.511.43-0.470.86
Net Income Before Taxes 43.5744.78104.1260.70
Provisionfor Income Taxes 13.21-0.718.258.43
Net Income After Taxes 30.3545.4995.8752.26
Net Income Before Extra Items 30.3545.4995.8752.26
Net Income 30.3545.4995.8752.26
Income Availableto Com Excl Extra Ord 30.3545.4995.8752.26
Income Availableto Com Incl Extra Ord 30.3545.4995.8752.26
Diluted Net Income 30.3545.4995.8752.26
Diluted Weighted Average Shares 2.292.222.152.22
Diluted EPS Excluding Extra Ord Items 13.2620.5244.5923.58
DPS- Common Stock Primary Issue 2.002.002.000.00
Diluted Normalized EPS 13.2621.5744.6223.59
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts